Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine

This publication has 42 references indexed in Scilit:

• Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
  Vaccine, 2006
• A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
  Vaccine, 2006
• Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
  The EMBO Journal, 2005
• Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
  Virology, 2005
• Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain
  Vaccine, 2005
• Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
  Published by Elsevier ,2004
• Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
  Proceedings of the National Academy of Sciences, 2004
• Caution Urged on SARS Vaccines
  Science, 2004
• The Secret Life of ACE2 as a Receptor for the SARS Virus
  Cell, 2003
• Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China
  Science, 2003